Acetaminophen Toxicity Completed Phase 1 Trials for Chlorpheniramine (DB01114)

IndicationStatusPhase
DBCOND0041257 (Acetaminophen Toxicity)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03451487A Study to Evaluate the Pharmacokinetics of Acetaminophen and Its Toxic Metabolites With 2 Formulations (Panadol and SafeTynadol) in Healthy VolunteersOther